ARCHIVES

Avastin Phase III Trial Meets Endpoint: PFS in Platinum-Sensitive Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

In Brief: NCAB To Hear NCOG Appeal; FDA Renege On New Toxicology Protocol, Holds Up INDs

April 24, 1981

Markison leaving Bristol-Myers, two others promoted in reorganization.

January 30, 2004

NIH Panel Finds Older GI Imaging Tool Still Useful In Treating Pancreatic Diseases

February 22, 2002

Committee Drafts QRA Definition

November 19, 1982

Sarcoma Survivors At Risk Of Blood Clots, Study Finds

May 25, 2007

ASCO Hit On Two Sides; AACR Split Criticized

June 26, 1992